Skip to Content MayoACCESS MayoLINK...
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) - Insights
Divyanshu (Div) Dubey, M.B.B.S., describes Mayo Clinic Laboratories' new diagnostic test for CIDP, or chronic inflammatory demyelinating polyneuropathy. The new test detects two antibodies — NF155 and CNTN1 — to enhance diagnosis and guide...
Mayo Clinic Laboratory and Pathology Research Roundup: July 9 - Insights
This week’s Research Roundup highlights the association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer.
Our interactive learning modules encompass many of the necessary skills to further develop your knowledge and skills on your journey as a phlebotomist.
Pathways Case Studies: June 2022 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for June include the following sub-specialties: Dermatopathology, Gastroenterology...
Pathways Case Studies: February 2021 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for February include the following sub-specialties: Neuropathology,...
https://news.mayocliniclabs.com/file-activity-metrics-qrg/
Activity Metrics Quick Reference Guide 800-533-1710 mayocliniclabs.com Effective Date: 9/26/2024 Log in to Activity Metrics 1. On MayoClinicLabs.com, at top right, click My Dashboard. 2. Enter your Professional username (email...
CPT codes and LOINC update: March 2023 - Insights
This page includes updates posted to Mayo Clinic Labs during the month of March.
Units of Measurement - Mayo Clinic Laboratories
Units of Measure A list of common units used in the reporting of our assays has been defined. Refer to the table for these units as well as the recommended report abbreviations. Last updated: February 27, 2024...
According to Mayo Clinic research published in JAMA, six genes contain mutations that may be passed down in families, substantially increasing a person’s risk for pancreatic cancer.